Bipartisan Federal Legislation to Address Insulin Access and Affordability.

Q3 Medicine

Diabetes Spectrum Pub Date : 2021-11-01 Epub Date: 2021-06-30 DOI:10.2337/ds21-0008

Mariana P Socal, Ge Bai

引用次数: 0

Abstract

Insulin access and affordability affect the well-being of millions of Americans. In the 116th Congress (2019-2020), seven bipartisan bills were introduced to address this issue. In this article, the authors group the seven bills into five categories (enhancing price transparency, limiting cost-sharing, changing biosimilar regulations, certifying prices, and permitting importation), summarize the main content of these bills, and discuss their implications. Understanding the bipartisan insulin pricing policy proposals can facilitate the development of a feasible legislative agenda to improve insulin access and affordability.

查看原文本刊更多论文

解决胰岛素可及性和可负担性的两党联邦立法。

胰岛素的可及性和可负担性影响着数百万美国人的福祉。在第 116 届国会（2019-2020 年）中，两党提出了七项法案来解决这一问题。在本文中，作者将这七项法案分为五类（提高价格透明度、限制成本分摊、修改生物仿制药法规、认证价格和允许进口），总结了这些法案的主要内容，并讨论了它们的影响。了解两党的胰岛素定价政策提案有助于制定可行的立法议程，以改善胰岛素的可及性和可负担性。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Diabetes Spectrum Medicine-Internal Medicine

CiteScore

2.70

自引率

0.00%

发文量

期刊介绍： The mission of Diabetes Spectrum: From Research to Practice is to assist health care professionals in the development of strategies to individualize treatment and diabetes self-management education for improved quality of life and diabetes control. These goals are achieved by presenting review as well as original, peer-reviewed articles on topics in clinical diabetes management, professional and patient education, nutrition, behavioral science and counseling, educational program development, and advocacy. In each issue, the FROM RESEARCH TO PRACTICE section explores, in depth, a diabetes care topic and provides practical application of current research findings.